Literature DB >> 15224593

Relationships between the histological grade of cutaneous mast cell tumours in dogs, their survival and the efficacy of surgical resection.

S Murphy1, A H Sparkes, K C Smith, A S Blunden, M J Brearley.   

Abstract

The histological grade of 340 cutaneous mast cell tumours derived from 280 dogs was determined by an established histological grading system; 87 of the tumours (26 per cent) were well differentiated, 199 (59 per cent) were intermediately differentiated and 54 (16 per cent) were poorly differentiated. The one-year survival rates for the dogs with tumours of these three grades were significantly different (P = 0.0001), being 100 per cent, 92 per cent and 46 per cent, respectively. The median survival time for the dogs with poorly differentiated tumours was 278 days, significantly shorter than that for the dogs with either intermediately or well-differentiated tumours, which were both over 1300 days. Regrowth of the tumours was identified in 10 (19 per cent) of the dogs with poorly differentiated tumours, 12 (6 per cent) of the dogs with intermediately differentiated tumours and one of the dogs with well-differentiated tumours; only three of the tumours which regrew had initially had complete margins. The results suggest that wide surgical margins are not a prerequisite for a successful long-term outcome in dogs with well-differentiated cutaneous mast cell tumours.

Entities:  

Mesh:

Year:  2004        PMID: 15224593     DOI: 10.1136/vr.154.24.743

Source DB:  PubMed          Journal:  Vet Rec        ISSN: 0042-4900            Impact factor:   2.695


  18 in total

1.  Factors influencing complete tumor excision of mast cell tumors and soft tissue sarcomas: a retrospective study in 100 dogs.

Authors:  Beatriz Monteiro; Sarah Boston; Gabrielle Monteith
Journal:  Can Vet J       Date:  2011-11       Impact factor: 1.008

2.  Multivariate survival analysis of histological parameters and clinical presentation in canine cutaneous mast cell tumours.

Authors:  R Preziosi; G Sarli; M Paltrinieri
Journal:  Vet Res Commun       Date:  2006-12-29       Impact factor: 2.459

3.  Predictive ability of fine-needle aspirate cytology for incompletely resected mast cell tumor surgical sites.

Authors:  Christopher E Lee; Stephanie S Lindley; Annette N Smith; Philippe Gaillard; Ralph A Henderson; Brad M Matz
Journal:  Can Vet J       Date:  2021-02       Impact factor: 1.008

4.  Safety evaluation of combination vinblastine and toceranib phosphate (Palladia®) in dogs: a phase I dose-finding study.

Authors:  C Robat; C London; L Bunting; L McCartan; N Stingle; K Selting; I Kurzman; D M Vail
Journal:  Vet Comp Oncol       Date:  2011-01-31       Impact factor: 2.613

5.  Combination vinblastine and palladia for high-grade and metastatic mast cell tumors in dogs.

Authors:  Johanna E Todd; Sandra M Nguyen; Joanna White; Veronika Langova; Penelope M Thomas; Sophia Tzannes
Journal:  Can Vet J       Date:  2021-12       Impact factor: 1.008

6.  Τhe Effect of Opioid Administration on Cytologic and Histopathologic Diagnosis of Canine Cutaneous Mast Cell Tumors Treated by Surgical Excision.

Authors:  Christina Marouda; Tilemahos Anagnostou; Ioannis Savvas; Lysimachos G Papazoglou; Dimitra Psalla
Journal:  Vet Sci       Date:  2022-04-22

7.  Canine mast cell tumours part I: Clinical and survival outcomes.

Authors:  Vanessa S Tamlin; Cynthia D K Bottema; Lucy Woolford; Elizabeth C Dobson; Allan E Kessell; Anne E Peaston
Journal:  Vet Med Sci       Date:  2022-05-03

8.  Aggressive local therapy combined with systemic chemotherapy provides long-term control in grade II stage 2 canine mast cell tumour: 21 cases (1999-2012).

Authors:  A Lejeune; K Skorupski; S Frazier; I Vanhaezebrouck; R B Rebhun; C M Reilly; C O Rodriguez
Journal:  Vet Comp Oncol       Date:  2013-05-31       Impact factor: 2.613

9.  Evaluation of information presented within mast cell tumour histopathology reports in the United States: 2012-2015.

Authors:  Jennifer K Reagan; Laura E Selmic; Caroline Fallon; Elizabeth A Driskell; Laura D Garrett
Journal:  Vet Med Sci       Date:  2018-06-07

10.  Epidemiological assessment of the risk of canine mast cell tumours based on the Kiupel two-grade malignancy classification.

Authors:  Anna Śmiech; Brygida Ślaska; Wojciech Łopuszyński; Agnieszka Jasik; Diana Bochyńska; Roman Dąbrowski
Journal:  Acta Vet Scand       Date:  2018-11-03       Impact factor: 1.695

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.